We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Handheld Immunoanalyzer Performs Laboratory Tests near Patient without Sacrificing Sensitivity and Precision

By HospiMedica International staff writers
Posted on 22 Mar 2023

Near Patient Testing (NPT), also known as Point of Care Testing (POCT), is a rapidly growing area within the field of In vitro diagnostics (IVDs). More...

NPT is now recognized for its key role in making services more patient-centered by bringing diagnostic testing closer to the patient. This shift has the potential to significantly transform the way healthcare services are delivered to patients. By enabling timely diagnosis at the bedside, in community settings, or even in general practice, the delivery of care can be made much more efficient, allowing patients to receive the right diagnosis and treatment in a timely and convenient manner. Now, a handheld portable immunoanalyzer with the sensitivity and precision of centralized laboratory equipment is currently being developed in a form factor suitable for low-cost, point-of-care testing anywhere in the world.

Proxim Diagnostics Corp. (Santa Clara, CA, USA) is developing the Profile System, a portable and fully automated immunodiagnostic device that can run several types of multiplexed assays using disposable cartridges. The system performs critical laboratory tests near the patient using whole blood without sacrificing sensitivity and precision to deliver the most critical information to the doctors right when they need it. The Profile System is battery operated, and offers a touch-screen display interface, along with wireless, Ethernet, and USB connectivity.

The handheld device is expected to enhance the ability of clinicians to perform rapid, high-quality testing at the point of care, such as in emergency rooms, intensive care units, nursing homes, community/remote clinics and in-home care, as well as in disaster relief and defense situations. The system is currently available for research use only. Proxim is also developing several immunoassays for sepsis, cardiology, and infectious diseases that can match the sensitivity and precision of tests that are run on larger, centralized laboratory equipment.

Related Links:
Proxim Diagnostics Corp.


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
New
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.